Open AccessRole of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
Author(s) -
Wolsk Emil,
Claggett Brian,
Pfeffer Marc A.,
Diaz Rafael,
Dickstein Kenneth,
Gerstein Hertzel C.,
Lawson Francesca C.,
Lewis Eldrin F.,
Maggioni Aldo P.,
McMurray John J. V.,
Probstfield Jeffrey L.,
Riddle Matthew C.,
Solomon Scott D.,
Tardif JeanClaude,
Køber Lars
Publication year - 2017
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.116.004743
Subject(s) - medicine , natriuretic peptide , heart failure , prohormone , cardiology , acute coronary syndrome , diabetes mellitus , type 2 diabetes mellitus , brain natriuretic peptide , myocardial infarction , endocrinology , hormone
Natriuretic peptides are recognized as important predictors of cardiovascular events in patients with heart failure, but less is known about their prognostic importance in patients with acute coronary syndrome. We sought to determine whether B-type natriuretic peptide (BNP) and N-terminal prohormone B-type natriuretic peptide (NT-proBNP) could enhance risk prediction of a broad range of cardiovascular outcomes in patients with acute coronary syndrome and type 2 diabetes mellitus.